BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 14688445)

  • 1. Hypothalamic neuropeptide Y/Y1 receptor pathway activated by a reduction in circulating leptin, but not by an increase in circulating ghrelin, contributes to hyperphagia associated with triiodothyronine-induced thyrotoxicosis.
    Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
    Neuroendocrinology; 2003 Dec; 78(6):321-30. PubMed ID: 14688445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of ghrelin in streptozotocin-induced diabetic hyperphagia.
    Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
    Endocrinology; 2002 Dec; 143(12):4934-7. PubMed ID: 12446621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperphagia and obesity produced by arcuate injection of NPY-saporin do not require upregulation of lateral hypothalamic orexigenic peptide genes.
    Li AJ; Dinh TT; Ritter S
    Peptides; 2008 Oct; 29(10):1732-9. PubMed ID: 18577407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of methamphetamine on expression of neuropeptide Y mRNA in hypothalamus and on serum leptin and ghrelin concentrations in ad libitum-fed and schedule-fed rats.
    Crowley WR; Ramoz G; Keefe KA; Torto R; Kalra SP; Hanson GR
    Neuroscience; 2005; 132(1):167-73. PubMed ID: 15780475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipogenic and orexigenic effects of the ghrelin-receptor ligand tabimorelin are diminished in leptin-signalling-deficient ZDF rats.
    Holm AM; Johansen PB; Ahnfelt-Rønne I; Rømer J
    Eur J Endocrinol; 2004 Jun; 150(6):893-904. PubMed ID: 15191361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triiodothyronine (T3) stimulates food intake via enhanced hypothalamic AMP-activated kinase activity.
    Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
    Regul Pept; 2008 Nov; 151(1-3):164-9. PubMed ID: 18708095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Thyroid hormone and various other hormones regulate hypothalamic neuropeptide Y (NPY) expression and feeding behavior].
    Ishii S; Kamegai J
    Nihon Yakurigaku Zasshi; 2006 Feb; 127(2):77-82. PubMed ID: 16595976
    [No Abstract]   [Full Text] [Related]  

  • 8. Sex-associated differences in the leptin and ghrelin systems related with the induction of hyperphagia under high-fat diet exposure in rats.
    Priego T; Sánchez J; Picó C; Palou A
    Horm Behav; 2009 Jan; 55(1):33-40. PubMed ID: 18718472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of adrenalectomy on AGRP, POMC, NPY and CART gene expression in the basal hypothalamus of fed and fasted rats.
    Savontaus E; Conwell IM; Wardlaw SL
    Brain Res; 2002 Dec; 958(1):130-8. PubMed ID: 12468037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of streptozotocin-induced diabetes and insulin treatment on the hypothalamic melanocortin system and muscle uncoupling protein 3 expression in rats.
    Havel PJ; Hahn TM; Sindelar DK; Baskin DG; Dallman MF; Weigle DS; Schwartz MW
    Diabetes; 2000 Feb; 49(2):244-52. PubMed ID: 10868941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphagia and central mechanisms for leptin resistance during pregnancy.
    Trujillo ML; Spuch C; Carro E; Señarís R
    Endocrinology; 2011 Apr; 152(4):1355-65. PubMed ID: 21303957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway.
    Shintani M; Ogawa Y; Ebihara K; Aizawa-Abe M; Miyanaga F; Takaya K; Hayashi T; Inoue G; Hosoda K; Kojima M; Kangawa K; Nakao K
    Diabetes; 2001 Feb; 50(2):227-32. PubMed ID: 11272130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y (NPY) Y1 receptor mRNA is upregulated in association with transient hyperphagia and body weight gain: evidence for a hypothalamic site for concurrent development of leptin resistance.
    Kalra PS; Dube MG; Xu B; Farmerie WG; Kalra SP
    J Neuroendocrinol; 1998 Jan; 10(1):43-9. PubMed ID: 9510057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating hormones and hypothalamic energy balance: regulatory gene expression in the Lou/C and Wistar rats.
    Mitchell SE; Nogueiras R; Rance K; Rayner DV; Wood S; Dieguez C; Williams LM
    J Endocrinol; 2006 Sep; 190(3):571-9. PubMed ID: 17003258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daily changes in hypothalamic gene expression of neuropeptide Y, galanin, proopiomelanocortin, and adipocyte leptin gene expression and secretion: effects of food restriction.
    Xu B; Kalra PS; Farmerie WG; Kalra SP
    Endocrinology; 1999 Jun; 140(6):2868-75. PubMed ID: 10342879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypothalamic neuropeptides, not leptin sensitivity, contributes to the hyperphagia in lactating Brandt's voles, Lasiopodomys brandtii.
    Cui JG; Tang GB; Wang DH
    J Exp Biol; 2011 Jul; 214(Pt 13):2242-7. PubMed ID: 21653818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leptin regulates appetite-related neuropeptides in the hypothalamus of developing rats without affecting food intake.
    Proulx K; Richard D; Walker CD
    Endocrinology; 2002 Dec; 143(12):4683-92. PubMed ID: 12446596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: comparison with leptin.
    Xu B; Dube MG; Kalra PS; Farmerie WG; Kaibara A; Moldawer LL; Martin D; Kalra SP
    Endocrinology; 1998 Feb; 139(2):466-73. PubMed ID: 9449612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic blockade of the melanocortin 4 receptor subtype leads to obesity independently of neuropeptide Y action, with no adverse effects on the gonadotropic and somatotropic axes.
    Raposinho PD; Castillo E; d'Alleves V; Broqua P; Pralong FP; Aubert ML
    Endocrinology; 2000 Dec; 141(12):4419-27. PubMed ID: 11108250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.